The action of novel chloramphenicol analogues on prokaryotic and eukaryotic systems.
D049148:Aminoacylation; D001665:Binding Sites; D001853:Bone Marrow / Q000378:metabolism; D001854:Bone Marrow Cells; D002247:Carbon Isotopes; D002478:Cells, Cultured; D002701:Chloramphenicol / Q000494:pharmacology*; D003600:Cytosol / Q000201:enzymology; D004247:DNA / Q000096:biosynthesis; D004926:Escherichia coli / Q000378:metabolism; D006801:Humans; D037102:Lectins; D007928:Lethal Dose 50; D008099:Liver / Q000166:cytology / Q000378:metabolism; D008213:Lymphocyte Activation; D008214:Lymphocytes; D008928:Mitochondria / Q000378:metabolism; D011485:Protein Binding; D014176:Protein Biosynthesis / Q000187:drug effects*; D012313:RNA / Q000096:biosynthesis*; D012156:Reticulocytes / Q000166:cytology / Q000378:metabolism; D012270:Ribosomes / Q000378:metabolism; D013997:Time Factors; D014316:Tritium
D002247:Carbon Isotopes; D037102:Lectins; D014316:Tritium; D012313:RNA; D002701:Chloramphenicol; D004247:DNA